Summary

The mineral supplements market is witnessing substantial growth due to increasing consumer awareness regarding preventive healthcare, nutritional deficiencies, and overall wellness. Rising adoption of dietary supplements among adults, geriatric populations, and health-conscious consumers is significantly contributing to industry expansion. Growing focus on immunity enhancement, bone health, and cardiovascular wellness is further driving product demand worldwide. The market is projected to increase from US$ 17.9 Bn in 2026 to US$ 30.1 Bn by 2033, registering a CAGR of 7.70% during the forecast period.

Market Insights:

The mineral supplements industry is evolving rapidly with increasing innovation in supplement formulations, delivery formats, and ingredient combinations. Manufacturers are introducing advanced formulations with improved bioavailability and absorption efficiency to enhance health outcomes. Growing consumer preference for clean-label, plant-based, and naturally sourced supplements is reshaping product development strategies across the industry.

Digital health awareness campaigns and the expansion of e-commerce platforms are also supporting market penetration across both developed and developing regions. Consumers are increasingly purchasing mineral supplements through online channels due to convenience, broader product availability, and personalized wellness recommendations. Additionally, rising investments in nutritional research and development are enabling companies to introduce targeted supplements for specific health conditions and demographic groups.

The market is also benefiting from increasing fitness awareness and growing participation in sports and wellness activities. Consumers are actively seeking supplements that support energy metabolism, muscle recovery, immunity enhancement, and long-term health maintenance. The expansion of preventive healthcare initiatives by governments and healthcare organizations is further strengthening market growth globally.

Drivers:

Several factors are driving the growth of the mineral supplements market. One of the major growth drivers is the increasing prevalence of micronutrient deficiencies caused by poor dietary habits, fast-paced lifestyles, and limited nutrient intake. Rising health consciousness among consumers is encouraging the adoption of nutritional supplements to maintain overall wellness and prevent chronic diseases.

The growing geriatric population is another key factor supporting market expansion. Aging individuals often require additional nutritional support to maintain bone density, cardiovascular health, and immune function, leading to increased demand for mineral supplementation products. Rising incidence of osteoporosis, anemia, and mineral deficiency disorders is also boosting the use of calcium, iron, and magnesium supplements.

Increased awareness regarding prenatal nutrition and child health is driving demand among pregnant women and pediatric populations. Healthcare providers are increasingly recommending mineral supplements during pregnancy and early childhood to support healthy growth and development. Furthermore, advancements in formulation technologies and flavored supplement formats are improving product acceptance among children and younger consumers.

Business Opportunity:

The mineral supplements market presents significant business opportunities for manufacturers, wellness brands, and healthcare providers. Companies are focusing on expanding their product portfolios with innovative formulations tailored to specific health needs and consumer preferences. Personalized nutrition solutions and customized supplementation programs are expected to create lucrative opportunities for market participants.

Emerging economies offer strong growth potential due to rising disposable income, increasing urbanization, and improving healthcare awareness. Expansion of retail pharmacy networks and online supplement sales platforms is also enabling companies to reach a broader consumer base. Strategic partnerships between supplement manufacturers, fitness brands, and healthcare professionals are expected to accelerate product adoption and market expansion.

The growing trend toward plant-based nutrition and organic supplements is creating opportunities for companies investing in sustainable and naturally sourced ingredients. Manufacturers focusing on transparency, product quality, and clinically supported formulations are expected to strengthen their competitive advantage in the global market.

Region Analysis:

North America dominates the mineral supplements market owing to high consumer awareness regarding preventive healthcare, strong purchasing power, and widespread adoption of dietary supplements. The region benefits from advanced healthcare infrastructure, increasing wellness trends, and a strong presence of nutritional supplement manufacturers. Rising demand for immunity support and bone health supplements continues to support regional market growth.

Europe represents a significant market due to increasing focus on healthy aging, nutritional awareness, and preventive healthcare practices. Consumers across the region are increasingly adopting dietary supplements to maintain overall health and address lifestyle-related nutritional deficiencies. Supportive regulatory frameworks and growing investments in nutritional research are further contributing to market expansion.

East Asia and South Asia & Oceania are expected to witness rapid growth during the forecast period due to rising population, urbanization, and increasing healthcare expenditure. Growing awareness regarding nutritional deficiencies and expanding middle-class populations are significantly driving supplement consumption across countries such as China and India.

Latin America is gradually emerging as a promising market supported by improving healthcare awareness and increasing availability of dietary supplements. Meanwhile, the Middle East and Africa region is witnessing steady growth due to rising health consciousness, growing retail distribution networks, and increasing adoption of preventive wellness products.

Key Players:

• Herbalife, Ltd

• Glanbia Plc

• Nu Skin Enterprises, Inc.

• E. I. du Pont de Nemours and Company

• NBTY, Inc.

• BASF SE

• Bayer AG

• Atrium Innovations, Inc.

• Amway

• Others

Segmentation:

By Product

• Calcium

• Magnesium

• Iron

• Potassium

• Zinc

• Chromium

• Selenium

• Others

By Formulation

• Tablets

• Capsules / Softgel

• Powders

• Liquids / Gels

• Gummies / Chewable Formats

• Others

By Application

• General Health & Wellness

• Bone & Joint Health

• Gastrointestinal Health

• Immunity Support

• Cardiovascular Health

• Others

By Target Demographic

• Adults

• Geriatric

• Pregnant Women

• Children

• Infants

By Region

• North America

• Europe

• East Asia

• South Asia & Oceania

• Latin America

• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Hormonal Contraceptives Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Hormonal Contraceptives Market Outlook, 2020 - 2033
3.1. Global Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
3.1.1. Calcium
3.1.2. Magnesium
3.1.3. Iron
3.1.4. Potassium
3.1.5. Zinc
3.1.6. Chromium
3.1.7. Selenium
3.1.8. Others
3.2. Global Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
3.2.1. Tablets
3.2.2. Capsules / Softgel
3.2.3. Powders
3.2.4. Liquids / Gels
3.2.5. Gummies / Chewable Formats
3.3. Global Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
3.3.1. General Health & Wellness
3.3.2. Bone & Joint Health
3.3.3. Gastrointestinal Health
3.3.4. Immunity Support
3.3.5. Cardiovascular Health
3.3.6. Others
3.4. Global Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
3.4.1. Adults
3.4.2. Geriatric
3.4.3. Pregnant Women
3.4.4. Children
3.4.5. Infants
3.5. Global Hormonal Contraceptives Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. Middle East & Africa
4. North America Hormonal Contraceptives Market Outlook, 2020 - 2033
4.1. North America Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
4.1.1. Calcium
4.1.2. Magnesium
4.1.3. Iron
4.1.4. Potassium
4.1.5. Zinc
4.1.6. Chromium
4.1.7. Selenium
4.1.8. Others
4.2. North America Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
4.2.1. Tablets
4.2.2. Capsules / Softgel
4.2.3. Powders
4.2.4. Liquids / Gels
4.2.5. Gummies / Chewable Formats
4.3. North America Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
4.3.1. General Health & Wellness
4.3.2. Bone & Joint Health
4.3.3. Gastrointestinal Health
4.3.4. Immunity Support
4.3.5. Cardiovascular Health
4.3.6. Others
4.4. North America Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
4.4.1. Adults
4.4.2. Geriatric
4.4.3. Pregnant Women
4.4.4. Children
4.4.5. Infants
4.5. North America Hormonal Contraceptives Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.5.1. U.S. Hormonal Contraceptives Market Outlook, by Product, 2020-2033
4.5.2. U.S. Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
4.5.3. U.S. Hormonal Contraceptives Market Outlook, by Application, 2020-2033
4.5.4. U.S. Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
4.5.5. Canada Hormonal Contraceptives Market Outlook, by Product, 2020-2033
4.5.6. Canada Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
4.5.7. Canada Hormonal Contraceptives Market Outlook, by Application, 2020-2033
4.5.8. Canada Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Hormonal Contraceptives Market Outlook, 2020 - 2033
5.1. Europe Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
5.1.1. Calcium
5.1.2. Magnesium
5.1.3. Iron
5.1.4. Potassium
5.1.5. Zinc
5.1.6. Chromium
5.1.7. Selenium
5.1.8. Others
5.2. Europe Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
5.2.1. Tablets
5.2.2. Capsules / Softgel
5.2.3. Powders
5.2.4. Liquids / Gels
5.2.5. Gummies / Chewable Formats
5.3. Europe Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
5.3.1. General Health & Wellness
5.3.2. Bone & Joint Health
5.3.3. Gastrointestinal Health
5.3.4. Immunity Support
5.3.5. Cardiovascular Health
5.3.6. Others
5.4. Europe Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
5.4.1. Adults
5.4.2. Geriatric
5.4.3. Pregnant Women
5.4.4. Children
5.4.5. Infants
5.5. Europe Hormonal Contraceptives Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.5.1. Germany Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.2. Germany Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.3. Germany Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.4. Germany Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.5. Italy Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.6. Italy Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.7. Italy Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.8. Italy Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.9. France Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.10. France Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.11. France Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.12. France Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.13. U.K. Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.14. U.K. Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.15. U.K. Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.16. U.K. Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.17. Spain Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.18. Spain Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.19. Spain Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.20. Spain Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.21. Russia Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.22. Russia Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.23. Russia Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.24. Russia Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.5.25. Rest of Europe Hormonal Contraceptives Market Outlook, by Product, 2020-2033
5.5.26. Rest of Europe Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
5.5.27. Rest of Europe Hormonal Contraceptives Market Outlook, by Application, 2020-2033
5.5.28. Rest of Europe Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Hormonal Contraceptives Market Outlook, 2020 - 2033
6.1. Asia Pacific Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
6.1.1. Calcium
6.1.2. Magnesium
6.1.3. Iron
6.1.4. Potassium
6.1.5. Zinc
6.1.6. Chromium
6.1.7. Selenium
6.1.8. Others
6.2. Asia Pacific Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
6.2.1. Tablets
6.2.2. Capsules / Softgel
6.2.3. Powders
6.2.4. Liquids / Gels
6.2.5. Gummies / Chewable Formats
6.3. Asia Pacific Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
6.3.1. General Health & Wellness
6.3.2. Bone & Joint Health
6.3.3. Gastrointestinal Health
6.3.4. Immunity Support
6.3.5. Cardiovascular Health
6.3.6. Others
6.4. Asia Pacific Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
6.4.1. Adults
6.4.2. Geriatric
6.4.3. Pregnant Women
6.4.4. Children
6.4.5. Infants
6.5. Asia Pacific Hormonal Contraceptives Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.5.1. China Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.2. China Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.3. China Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.4. China Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.5.5. Japan Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.6. Japan Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.7. Japan Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.8. Japan Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.5.9. South Korea Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.10. South Korea Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.11. South Korea Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.12. South Korea Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.5.13. India Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.14. India Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.15. India Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.16. India Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.5.17. Southeast Asia Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.18. Southeast Asia Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.19. Southeast Asia Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.20. Southeast Asia Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.5.21. Rest of SAO Hormonal Contraceptives Market Outlook, by Product, 2020-2033
6.5.22. Rest of SAO Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
6.5.23. Rest of SAO Hormonal Contraceptives Market Outlook, by Application, 2020-2033
6.5.24. Rest of SAO Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Hormonal Contraceptives Market Outlook, 2020 - 2033
7.1. Latin America Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
7.1.1. Calcium
7.1.2. Magnesium
7.1.3. Iron
7.1.4. Potassium
7.1.5. Zinc
7.1.6. Chromium
7.1.7. Selenium
7.1.8. Others
7.2. Latin America Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
7.2.1. Tablets
7.2.2. Capsules / Softgel
7.2.3. Powders
7.2.4. Liquids / Gels
7.2.5. Gummies / Chewable Formats
7.3. Latin America Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
7.3.1. General Health & Wellness
7.3.2. Bone & Joint Health
7.3.3. Gastrointestinal Health
7.3.4. Immunity Support
7.3.5. Cardiovascular Health
7.3.6. Others
7.4. Latin America Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
7.4.1. Adults
7.4.2. Geriatric
7.4.3. Pregnant Women
7.4.4. Children
7.4.5. Infants
7.5. Latin America Hormonal Contraceptives Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.5.1. Brazil Hormonal Contraceptives Market Outlook, by Product, 2020-2033
7.5.2. Brazil Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
7.5.3. Brazil Hormonal Contraceptives Market Outlook, by Application, 2020-2033
7.5.4. Brazil Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
7.5.5. Mexico Hormonal Contraceptives Market Outlook, by Product, 2020-2033
7.5.6. Mexico Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
7.5.7. Mexico Hormonal Contraceptives Market Outlook, by Application, 2020-2033
7.5.8. Mexico Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
7.5.9. Argentina Hormonal Contraceptives Market Outlook, by Product, 2020-2033
7.5.10. Argentina Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
7.5.11. Argentina Hormonal Contraceptives Market Outlook, by Application, 2020-2033
7.5.12. Argentina Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
7.5.13. Rest of LATAM Hormonal Contraceptives Market Outlook, by Product, 2020-2033
7.5.14. Rest of LATAM Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
7.5.15. Rest of LATAM Hormonal Contraceptives Market Outlook, by Application, 2020-2033
7.5.16. Rest of LATAM Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Hormonal Contraceptives Market Outlook, 2020 - 2033
8.1. Middle East & Africa Hormonal Contraceptives Market Outlook, by Product, Value (US$ Bn), 2020-2033
8.1.1. Calcium
8.1.2. Magnesium
8.1.3. Iron
8.1.4. Potassium
8.1.5. Zinc
8.1.6. Chromium
8.1.7. Selenium
8.1.8. Others
8.2. Middle East & Africa Hormonal Contraceptives Market Outlook, by Formulation, Value (US$ Bn), 2020-2033
8.2.1. Tablets
8.2.2. Capsules / Softgel
8.2.3. Powders
8.2.4. Liquids / Gels
8.2.5. Gummies / Chewable Formats
8.3. Middle East & Africa Hormonal Contraceptives Market Outlook, by Application, Value (US$ Bn), 2020-2033
8.3.1. General Health & Wellness
8.3.2. Bone & Joint Health
8.3.3. Gastrointestinal Health
8.3.4. Immunity Support
8.3.5. Cardiovascular Health
8.3.6. Others
8.4. Middle East & Africa Hormonal Contraceptives Market Outlook, by Target Demographic, Value (US$ Bn), 2020-2033
8.4.1. Adults
8.4.2. Geriatric
8.4.3. Pregnant Women
8.4.4. Children
8.4.5. Infants
8.5. Middle East & Africa Hormonal Contraceptives Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.5.1. GCC Hormonal Contraceptives Market Outlook, by Product, 2020-2033
8.5.2. GCC Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
8.5.3. GCC Hormonal Contraceptives Market Outlook, by Application, 2020-2033
8.5.4. GCC Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
8.5.5. South Africa Hormonal Contraceptives Market Outlook, by Product, 2020-2033
8.5.6. South Africa Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
8.5.7. South Africa Hormonal Contraceptives Market Outlook, by Application, 2020-2033
8.5.8. South Africa Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
8.5.9. Egypt Hormonal Contraceptives Market Outlook, by Product, 2020-2033
8.5.10. Egypt Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
8.5.11. Egypt Hormonal Contraceptives Market Outlook, by Application, 2020-2033
8.5.12. Egypt Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
8.5.13. Nigeria Hormonal Contraceptives Market Outlook, by Product, 2020-2033
8.5.14. Nigeria Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
8.5.15. Nigeria Hormonal Contraceptives Market Outlook, by Application, 2020-2033
8.5.16. Nigeria Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
8.5.17. Rest of Middle East Hormonal Contraceptives Market Outlook, by Product, 2020-2033
8.5.18. Rest of Middle East Hormonal Contraceptives Market Outlook, by Formulation, 2020-2033
8.5.19. Rest of Middle East Hormonal Contraceptives Market Outlook, by Application, 2020-2033
8.5.20. Rest of Middle East Hormonal Contraceptives Market Outlook, by Target Demographic, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Herbalife, Ltd
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Glanbia Plc
9.4.3. Nu Skin Enterprises, Inc.
9.4.4. E. I. du Pont de Nemours and Company
9.4.5. NBTY, Inc.
9.4.6. BASF SE
9.4.7. Bayer AG
9.4.8. Atrium Innovations, Inc.
9.4.9. Amway
9.4.10. Others
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations